Article

Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models

2022-06-22

Abstract excerpt

<h4>Summary</h4> The use of therapeutic neutralizing antibodies against SARS-CoV-2 infection has been highly effective. However, there remain few practical antibodies against viruses that are acquiring mutations. In this study, we created 494 monoclonal antibodies from COVID-19–convalescent patients, and identified antibodies that exhibited comparable neutralizing ability to clinically used antibodies in the neut...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 85274bf1-c131-5716-a56c-30b52284f063
DOI: 10.1101/2022.06.21.496751

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal modelsDOI 10.1101/2022.06.21.496751Read

SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibodySemantic proximity Read

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodiesSemantic proximity Read

Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster modelSemantic proximity Read

Broad Neutralizing Antibodies Against SARS-CoV-2: Current Progress and Engineering Strategies.Semantic proximity Read

Development and characterization of neutralizing antibodies against SRAS-CoV-2Semantic proximity Read

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopesSemantic proximity Read

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccinationSemantic proximity Read

A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBDSemantic proximity Read

The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.Semantic proximity Read

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsSemantic proximity Read

A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBDSemantic proximity Read

Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster modelsSemantic proximity Read